Gamma-glutamyltransferase and disability pension: a cohort study of construction workers in germany

Hepatology

Volumn 51, Issue 2, 2010, Pages 482-490

  Claessen, Heiner ^a   Brenner, Hermann ^a   Drath, Christoph ^b   Arndt, Volker ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b Workmen's Compensation Board for Construction Workers   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; GAMMA GLUTAMYLTRANSFERASE;

ADULT; AGE DISTRIBUTION; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CIGARETTE SMOKING; CITIZENSHIP; COHORT ANALYSIS; CONSTRUCTION WORK; CONTROLLED STUDY; DIGESTIVE SYSTEM DISEASE; FOLLOW UP; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GERMANY; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MUSCULOSKELETAL DISEASE; PENSION; PRIORITY JOURNAL; WORK DISABILITY;

ADULT; FOLLOW-UP STUDIES; GAMMA-GLUTAMYLTRANSFERASE; GERMANY; HUMANS; INSURANCE, DISABILITY; MALE; MIDDLE AGED; PENSIONS; RETROSPECTIVE STUDIES;

EID: 75449097148     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.23324     Document Type: Article

References (35)

1. Whitfield JB. Gamma glutamyl transferase. Crit Rev Clin Lab Sci 2001; 38:263-355.
2. Loew M, Boeing H, Stürmer T, Brenner H. Relation among alcohol dehydrogenase 2 polymorphism, alcohol consumption, and levels of gammaglutamyltransferase. Alcohol 2003;29:131-135.
3. Nilssen O, Førde OH, Brenn T. The Tromsø Study: distribution and population determinants of gamma-glutamyltransferase. Am J Epidemiol 1990;132:318-326.
4. Wannamethee G, Ebrahim S, Shaper AG. Gamma-glutamyltransferase: determinants and association with mortality from ischemic heart disease and all causes. Am J Epidemiol 1995;142:699-708.
5. Wannamethee SG, Shaper AG, Lennon L, Whincup PH. Hepatic enzymes, the metabolic syndrome, and the risk of type 2 diabetes in older men. Diabetes Care 2005;28:2913-2918.
6. Wannamethee SG, Lennon L, Shaper AG. The value of gamma- glutamyltransferase in cardiovascular risk prediction in men without diagnosed cardiovascular disease or diabetes. Atherosclerosis 2008;201:168-175.
7. Lee DH, Jacobs DR Jr, Gross M, Kiefe CI, Roseman J, Lewis CE, et al. Gamma-glutamyltransferase is a predictor of incident diabetes and hypertension: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Clin Chem 2003;49:1358-1366.
8. Meisinger C, Löwel H, Heier M, Schneider A, Thorand B, KORA Study Group. Serum gamma-glutamyltransferase and risk of type 2 diabetes mellitus in men and women from the general population. J Intern Med 2005; 258:527-535.
9. Lee DS, Evans JC, Robins SJ, Wilson PW, Albano I, Fox CS, et al. Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk: the Framingham Heart Study. Arterioscler Thromb Vasc Biol 2007;27:127-133.
10. Ryu S, Chang Y, Kim DI, Kim WS, Suh BS. Gamma-glutamyltransferase as a predictor of chronic kidney disease in nonhypertensive and nondiabetic Korean men. Clin Chem 2007;53:71-77.
11. Hayes RM, Beebe D, Kreamer H. Too sick to work, too soon for Medicare: the human cost of the 2-year Medicare waiting period for Americans with disabilities. Care Manag J 2008;9:82-88.
12. Stoddard S, Jans L, Ripple J, Kraus L. Chartbook on work and disability in the United States, 1998. An InfoUse Report. Washington, D.C.: U.S. National Institute on Disability and Rehabilitation Research.
13. Statistische Analysen Referat 0631: Results at a glance [Publication in German: Ergebnisse auf einen Blick Stand: Dezember 2008]. Deutsche Rentenversicherung. Accessed online December 12, 2008.
14. Statistik der Deutschen Rentenversicherung: Pension fund numerical 2008: [Publication in German: Rentenversicherung in Zahlen 2008]. Deutsche Rentenversicherung. Accessed online August 22, 2008.
15. Mansson NO, Israelsson B. Middle-aged men before and after disability pension. Health screening profile with special emphasis on alcohol consumption. Scand J Soc Med 1987;15:185-189.
16. Arndt V, Brenner H, Rothenbacher D, Zschenderlein B, Fraisse E, Fliedner TM. Elevated liver enzyme activity in construction workers: prevalence and impact on early retirement and all-cause mortality. Int Arch Occup Environ Health 1998;53:405-412.
17. Arndt V, Rothenbacher D, Brenner H, Fraisse E, Zschenderlein B, Daniel U, et al. Older workers in the construction industry: results of a routine health examination and a five year follow up. Occup Environ Med 1996; 53:686-691.
18. Arndt V, Rothenbacher D, Daniel U, Zschenderlein B, Schuberth S, Brenner H. Construction work and risk of occupational disability: a ten year follow up of 14 474 male workers. Occup Environ Med 2005;62:559-566.
19. Menhorn VZ, Reference values for enzymes changed [Article in German: Referenzwerte für Enzyme geändert]. Pharmazeutische Zeitung (Online-Ausgabe) 2003;31.
20. WHO Consultation on Obesity. Obesity: preventing and managing the global epidemic. WHO Technical Report Series 894. Geneva: World Health Organization; 2000:8-10.
21. Royston P, Ambler G, Sauerbrei W. The use of fractional polynomials to model continuous risk variables in epidemiology. Int J Epidemiol 1999; 28:964-974.
22. Sauerbrei W, Meier-Hirmer C, Benner A, Royston P. Multivariable regression model building by using fractional polynomials: description of SAS, STATA and R programs. Comput Stat Data Anal 2006;50:3464-3485.
23. Dong W, Vaughan P, Sullivan K, Fletcher T. Mortality study of construction workers in the UK. Int J Epidemiol 1995;24:750-757.
24. Arndt V, Rothenbacher D, Daniel U, Zschenderlein B, Schuberth S, Brenner H. All-cause and cause specific mortality in a cohort of 20 000 construction workers; results from a 10 year follow up. Occup Environ Med 2004;61:419-425.
25. Cherry NM, Labrèche FP, McDonald JC. Organic brain damage and occupational solvent exposure. Br J Ind Med 1992;49:776-781.
26. Yavuz BB, Yavuz B, Halil M, Cankurtaran M, Ulger Z, Cankurtaran ES, et al. Serum elevated gamma glutamyltransferase levels may be a marker for oxidative stress in Alzheimer's disease. Int Psychogeriatr 2008;20:815-823.
27. Pompella A, Corti A, Paolicchi A, Giommarelli C, Zunino F. Gammaglutamyltransferase, redox regulation and cancer drug resistance. Curr Opin Pharmacol 2007;7:360-366.
28. Pompella A, De Tata V, Paolicchi A, Zunino F. Expression of gammaglutamyltransferase in cancer cells and its significance in drug resistance. Biochem Pharmacol 2006;71:231-238.
29. Franzini M, Corti A, Lorenzini E, Paolicchi A, Pompella A, De Cesare M, et al. Modulation of cell growth and cisplatin sensitivity by membrane gamma-glutamyltransferase in melanoma cells. Eur J Cancer 2006;42: 2623-2630.
30. Hanigan MH, Gallagher BC, Townsend DM, Gabarra V. Gamma-glutamyl transpeptidase accelerates tumor growth and increases the resistance of tumors to cisplatin in vivo. Carcinogenesis 1999;20:553-559.
31. Petersson B, Trell E. Risk factors for premature death in middle aged men. BMJ 1984;288:1264-1268.
32. Strasak AM, Rapp K, Brant LJ, Hilbe W, Gregory M, Oberaigner W, et al. Association of gamma-glutamyltransferase and risk of cancer incidence in men: a prospective study. Cancer Res 2008;68:3970-3977.
33. Bergenudd H, Johnell O. Somatic versus nonsomatic shoulder and back pain experience in middle age in relation to body build, physical fitness, bone mineral content, gamma-glutamyltransferase, occupational workload, and psychosocial factors. Spine 1991;16:1051-1055.
34. Månsson NO, Merlo J. The relation between self-rated health, socioeconomic status, body mass index and disability pension among middle-aged men. Eur J Epidemiol 2001;17:65-69.
35. Wolf AM, Siadaty MS, Crowther JQ, Nadler JL, Wagner DL, Cavalieri SL, et al. Impact of lifestyle intervention on lost productivity and disability: improving control with activity and nutrition. J Occup Environ Med 2009;51:139-145.